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EXPERIMENTAL STUDIES
Coronary Collateral Development During
Chronic Ischemia: Serial Assessment Using
Harmonic Myocardial Contrast Echocardiography
James D. Mills, MD, FACC, David Fischer, BS, Flordeliza S. Villanueva, MD, FACC
Pittsburgh, Pennsylvania
OBJECTIVES We sought to characterize collateral development in an experimental model of chronic
myocardial ischemia by using myocardial contrast echocardiography (MCE).
BACKGROUND Coronary collaterals maintain myocyte viability during myocardial ischemia. The natural
history and determinants of collateral development are difficult to study serially in vivo.
METHODS The left anterior descending coronary artery (LAD) in nine dogs was encircled (day 0) with
a hydraulic occluder and ameroid constrictor to enable reversible and gradual total LAD
occlusion, respectively. Myocardial contrast echocardiography was performed using intrave-
nous injection of perfluorocarbon gas-containing microbubbles during two-dimensional
harmonic echocardiographic imaging. Myocardial contrast echocardiography images and
radiolabeled microsphere flow measurements were obtained during transient LAD occlusion
on day 0. Over the ensuing six weeks, MCE imaging was performed during LAD occlusion
at 10-day intervals.
RESULTS Myocardial contrast echocardiography risk area size (expressed as a percent of the left
ventricular short axis slice) decreased over the course of six weeks (32% 6 3% on day 0, 21%
6 3% at day 10, 5 6 3% at day 20, 1% 6 1% at day 30 and 1% 6 1% at day 42, p # 0.001
vs. day 0). Radiolabeled microsphere-derived LAD flow, normalized to left circumflex flow,
correspondingly increased between day 0 and day 42 (0.14 6 0.02 to 0.90 6 0.07, p , 0.02).
CONCLUSIONS Collateral development occurs relatively early and rapidly in this chronic canine model.
Myocardial contrast echocardiography using harmonic imaging and intravenous injection of
microbubbles can uniquely track the spatial and temporal course of collateral growth, and may
be a powerful tool for noninvasively mapping the efficacy of therapeutic angiogenic strategies
in vivo. (J Am Coll Cardiol 2000;36:618–24) © 2000 by the American College of
Cardiology
The coronary collateral circulation provides an alternate
supply of blood to myocardium at risk for necrosis during
coronary occlusion. Collateral vessels mitigate myocardial
ischemia (1), maintain myocyte viability during coronary
occlusion (2) and limit the extent of infarction (3,4). The
natural history and pathophysiologic determinants of angio-
genesis and vasculogenic growth are not completely under-
stood. Recent reports of successful attempts to stimulate
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angiogenesis in animal and human models of ischemia
(5–8) have spawned increasing interest in therapeutic an-
giogenesis and highlighted the need to demonstrate and
measure the efficacy of such treatments.
Current methods to assess the development of the coro-
nary collateral circulation have limitations. Coronary an-
giography, which is a common standard for clinically
evaluating collateral flow, visualizes vessels with intralumi-
nal diameters greater than 100 microns, whereas most
collaterals are smaller in size (9,10). Radiolabeled micro-
sphere technology is a postmortem method and has limited
spatial resolution (11), as do scintigraphic perfusion imaging
techniques (12).
Myocardial contrast echocardiography (MCE) is an ul-
trasound imaging technique that utilizes physiologically
inert gas-filled microbubbles as red blood cell tracers (13).
Because these microbubbles are acoustic scatterers as they
transit the microcirculation in the presence of ultrasound,
they delineate regional microvascular perfusion in vivo
(14,15). These properties make MCE a potentially attrac-
tive imaging approach for studying the collateral circulation,
but its requirement for intracoronary or intraaortic injection
of fragile microbubbles has heretofore relegated its clinical
application to invasive settings such as the cardiac catheter-
ization laboratory or operating room (16,17). The recent
development of more stable intravenous contrast agents and
new ultrasound imaging approaches, such as harmonic
imaging, has broadened the possibilities for using MCE in
a noninvasive setting (18–21).
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Based on these considerations, we sought to characterize
the temporal course and spatial extent of coronary collateral
development using MCE. We used a canine model of
chronic, progressive coronary occlusion to test the hypoth-
esis that serial harmonic echocardiographic imaging can
noninvasively evaluate the natural history of coronary col-
lateral development in real time.
METHODS
Surgical preparation. DAY 0: INITIAL INSTRUMENTATION. The
experimental protocol was approved by the Institutional Animal
Care and Use Committee at the University of Pittsburgh and
conformed to the American Heart Association Guidelines for Use
of Animals in Research. Nine adult dogs were premedicated with
transdermal fentanyl (75 mg/h), intravenous thiopental sodium
(15 mg/kg), intubated and ventilated. A 21G peripheral intrave-
nous catheter was placed in the forearm for administration of drugs
and microbubbles. General anesthesia was maintained with 0.5%
to 2.0%-inhaled isofluourane. Cefazolin (1.0–2.0 g, intravenous)
was administered just before surgery and hourly thereafter.
A left lateral thoracotomy was performed, and the heart was
suspended in a pericardial cradle. The right femoral artery was
percutaneously cannulated with a 5F catheter for arterial pressure
monitoring and radiolabeled microsphere reference sample with-
drawal. The proximal left anterior descending coronary artery
(LAD) was encircled with an ameroid constrictor (Research
Instruments, Corvallis, Oregon) appropriately sized to progres-
sively occlude the LAD by three weeks postoperatively (10).
Immediately adjacent to the ameroid constrictor, a hydraulic
balloon occluder (R.E. Jones Biomedical Products, Rockville,
Maryland) was placed around the LAD and subcutaneously
exteriorized to enable transient LAD occlusion during closed chest
imaging. A 7F catheter was placed in the left atrium for radiola-
beled microsphere injection.
The atrial and arterial catheters were removed before closure of
the pericardium and chest, the dogs were allowed to recover and
buprenorphine (6 mg/kg, intramuscular) was used for postoperative
pain. Aspirin (325 mg, orally) was administered daily for 24 days
to reduce the risk of acute thrombotic LAD occlusion.
In three dogs, a transit time flow probe (Transonic Systems
Inc., Ithaca, New York) was placed around the mid-LAD, left in
the chest and subcutaneously exteriorized upon chest closure. The
probe was used to document complete absence of anterograde
LAD flow during balloon occlusions. Additionally, serial flow
probe readings were used to confirm total ameroid-induced LAD
occlusion by three weeks postoperatively in our model.
Six weeks: terminal surgery. The dogs were returned to
the operative suite after six weeks, anesthetized with
30 mg/kg sodium pentobarbital, intubated and mechanically
ventilated. A left lateral thoracotomy was performed and the
heart was exposed. 7F catheters were placed in the left
atrium, femoral artery and femoral vein.
MCE. Harmonic B-mode MCE was performed using
either of two imaging systems: HDI 3000 (Advanced
Technology Laboratories, Bothell, Washington) transmit-
ting at 1.8 MHz and receiving 3.6 MHz or a Hewlett-
Packard 2500 prototype transmitting at 1.6 MHz and
receiving at 3.2 MHz). Mechanical index varied from 0.7 to
0.9 in a given dog. Gain, depth and mechanical index were
kept constant. Maximal dynamic range and a linear signal to
video postprocessing algorithm were chosen.
Open chest epicardial imaging was performed on the
initial and terminal days of surgery, while transthoracic
MCE was performed periodically during the subsequent
weeks. For these imaging sessions, conscious dogs were
lightly sedated with acepromazine (0.1 mg/kg, intramuscu-
lar) and positioned in the right lateral decubitus position.
Myocardial contrast echocardiography imaging at the
midpapillary muscle level in the short-axis plane was per-
formed at baseline and during LAD occlusion, with ultra-
sound pulsing electrocardiographically gated to end-systole
(19). Images were recorded on 1.25 cm sVHS videotape.
Microbubbles containing a mixture of gaseous perfluoro-
propane and air inside a bilayer phospholipid shell (Defin-
ity, DuPont Pharmaceuticals Company) was used as the
contrast agent. This agent has a mean diameter of 2.3
microns, concentration of 1.2 3 109 bubbles/ml and does
not produce significant physiologic changes (18). Myocar-
dial contrast echocardiography was performed by slowly
injecting 0.1 ml to 0.2 ml of the microbubbles through a
peripheral intravenous catheter during simultaneous echo-
cardiographic imaging.
Myocardial contrast echocardiography images were ana-
lyzed off-line using previously described digital subtraction
techniques (22): images were transferred from videotape to
image memory of a computer analysis system (Mipron,
Kontron Electronics, Germany). Consecutive end-systolic
frames were aligned using cross-correlation techniques, and
background-subtracted videointensity data were derived
from regions of interest in the LAD and left circumflex
coronary artery (LCX) beds as defined on day 0 during brief
LAD occlusion. Only regions of interest outside of attenu-
ated areas were selected.
A previously described approach using digital subtraction
and color-coding was used to delineate risk area size (22).
Briefly, three precontrast end-systolic frames were averaged,
and three contrast-enhanced end-systolic frames were sim-
ilarly averaged. The averaged precontrast frame was digitally
subtracted from the averaged contrast-enhanced frame. The
gray scale values on the subtracted image were color-coded
using a heated object color map, with red shades progressing
to orange, yellow and white colors representing incremental
degrees of contrast change (23). Regions with minimal
myocardial flow during occlusion (risk area) were repre-
Abbreviations and Acronyms
LAD 5 left anterior descending coronary artery
LCX 5 left circumflex coronary artery
MCE 5 myocardial contrast echocardiography
TTC 5 triphenyl tetrazolium chloride
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sented by little to no color enhancement and were planime-
tered and expressed as a percentage of the short-axis slice.
Determination of infarct size. Postmortem, the heart was
excised, sliced cross-sectionally from base to apex and
immersed in a solution of 1.3% 2,3,5-triphenyl tetrazolium
chloride (TTC) and 0.2 mol/L Sorensen’s buffer (KH2PO4
and K2HPO4 in distilled water, pH 7.4) at 37° C for
20 min, followed by fixation in 10% formalin. This method
stains viable areas brick red, while necrotic regions remain
unstained (24). The TTC-stained slices were digitized into
the off-line computer, and infarcted regions were planime-
tered and expressed as a percentage of the short-axis slice
(15).
Regional myocardial blood flow measurement. Regional
myocardial perfusion was measured using the radiolabeled
microsphere technique (11). Approximately 2 3 106 11-mm
radiolabeled microspheres (New England Nuclear, Boston,
Massachusetts) were suspended in 3 ml of 0.9% saline
solution/0.01% Tween 80. The microspheres were injected
into the left atrium, followed by a flush, during simulta-
neous 90 s reference sample withdrawal from the femoral
artery. The left ventricular short-axis slice corresponding to
the MCE image was sectioned into 16 pieces, which were
further divided into endocardial, midwall and epicardial
portions. Tissue and reference samples were weighed and
counted in a Gamma scintillation counter (model 5535,
Packard Instruments, Downer’s Grove, Illinois), and data
were transferred to a personal computer. Corrections for
energy spillover into neighboring windows were made using
customized software, and averaged transmural blood flow
(ml/min/g) was calculated as previously described (11).
Experimental protocol. The six-week experimental proto-
col is diagrammed in Figure 1. On day 0, epicardial MCE
was performed before and during transient LAD occlusion
in order to define the area at risk. Radiolabeled micro-
spheres (Sn113) were injected during transient LAD occlu-
sion to measure the initial collateral flow to the risk bed, and
the chest was closed as described above.
Over the ensuing weeks, transthoracic MCE was per-
formed three additional times at 10 day intervals with the
dog in the conscious state. Images were obtained at baseline
and during transient LAD occlusion using the externalized
perivascular balloon occluder to delineate changes in collat-
eral flow to the LAD risk bed.
Six weeks after instrumentation, the dog was returned to
the operative suite and instrumented as described above.
Myocardial contrast echocardiography imaging and radio-
labeled microsphere injections were performed after a silk
suture was tied around the LAD at the site of the ameroid.
The dog was euthanized with pentobarbital and potassium
chloride overdose, and the heart was excised and processed
as described above. In two dogs, coronary arteriography
performed three weeks after ameroid placement confirmed
total LAD occlusion.
Figure 1. Outline of six-week experimental protocol. LAD 5 left anterior
descending coronary artery; MCE 5 myocardial contrast echocardiogra-
phy; Usph 5 radiolabeled microspheres.
Figure 2. Myocardial contrast echocardiography images in one dog dem-
onstrating decrease in risk area size. On day 0 (panel A) there is a large
anteroseptal and anterior perfusion defect during transient acute LAD
occlusion (region between arrows), which is no longer present during
chronic occlusion six weeks later (panel B). The curved double yellow
lines schematically indicate the anterior right ventricular-left ventricular
junction.
Figure 3. Serial MCE images obtained in the same dog shown in Figure 2 at day 10 (panel A), day 20 (panel B) and day 30 (panel C). There is a
progressive decrease in perfusion defect size (region between arrows). The spatial orientation of these transthoracic images is opposite from the open chest
images shown in Figure 2. The curved double yellow lines schematically represent the anterior right ventricular-left ventricular junction.
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Statistical analysis. Data are expressed as mean 6 SEM.
Within-dog comparisons were made at successive time
points using repeated measures analysis of variance
(ANOVA). Paired t testing (2-tailed) was performed when
a significant difference was found, and Bonferroni criteria
were used to adjust for multiple comparisons. Statistical
significance was defined as p , 0.05.
RESULTS
Changes in MCE perfusion defect size. There was a
progressive decrease in MCE-determined risk area size
during the six-week period, as exemplified in Figure 2,
which illustrates serial open chest MCE images from one
dog during LAD occlusion on day 0 (panel A) and the
terminal day of the protocol (panel B). The left ventricle was
filled with contrast, resulting in mild posterior wall attenu-
ation in the field farthest from the transducer. On day 0,
MCE during acute LAD occlusion demonstrated a risk area
involving the anteroseptal and anterior segments (region
between arrows). By week six, despite the presence of total
LAD occlusion, there was homogeneous myocardial con-
trast enhancement, with contrast filling the region previ-
ously identified as the risk area on day 0.
Figure 3 depicts transthoracic images obtained during the
intervening weeks in the same dog shown in Figure 2.
Because the dog was imaged in the right lateral decubitus
position with the transducer on the right chest, the orien-
tation of the short-axis image is reversed from that in Figure
2: the anterior segments appear in the far field, and the
posterior segments and right ventricular cavity are in the
near-field. At 10 days (Panel A), there is a relative perfusion
defect that is smaller than that seen on day 0 (Fig. 2, Panel
A), indicated by the orange region in the anterior septum
(segment between arrows). By day 20 (Panel B), there is a
subtle, small region of relative hypoperfusion (orange region
between arrows), and by day 30 (Panel C) there is no
detectable risk area despite total LAD occlusion. As shown
in Panels A through C, the decrease in risk area size
appeared to be due to progressive inward migration of the
lateral and epicardial borders of the original risk bed, with
the lowest intensity remaining in the center of the area at
risk.
Of the nine dogs initially instrumented, one died sud-
denly two weeks after surgery. Figure 4 summarizes the risk
area data in the surviving eight dogs. There was a significant
decrease in perfusion defect size over time (p , 0.001). The
risk bed measured 32% 6 3% of the left ventricular
short-axis area on day 0 and decreased to 21% 6 3% at day
10, 5% 6 3% at day 20, 1% 6 1% at day 30 and 1% 6 1%
on the terminal day of the protocol. In the two dogs with a
persistent MCE defect on the terminal day, there was
evidence of subendocardial infarction on postmortem TTC-
staining, measuring 6% and 2% of the corresponding mid-
papillary short-axis slice, respectively.
The peak videointensity measurements in the LAD bed,
normalized to the LCX bed, are summarized in Figure 5.
There was a significant increase in the relative LAD peak
intensity between day 0 and the subsequent weeks (p ,
0.01), with the peak intensity nearly equivalent to LCX
intensity by the final day of imaging.
Radiolabeled microsphere flow. Changes in microsphere-
derived flow to the risk bed (expressed as LAD flow
normalized to LCX flow) paralleled the MCE findings.
There was a significant increase in collateral flow to the
LAD risk bed between day 0 and day 42 (0.14 6 0.05 vs.
0.90 6 0.04, p , 0.01).
DISCUSSION
We sought to prospectively characterize the temporal and
spatial development of coronary collaterals in a clinically
relevant model of chronic myocardial ischemia. This study
demonstrates that MCE, using harmonic imaging and
peripheral intravenous injection of microbubbles, can track
the spatial distribution and time course of coronary collat-
eral development in an ischemic bed over time. We suggest
that this method may yield pathophysiologic insight into
the process of collateral development and could be a
potentially valuable tool to serially study angiogenesis in the
clinical setting.
Natural history of collateral development in the canine
model. The dogs in this study had a substantial MCE-
defined risk area during transient LAD occlusion on day 0.
With the exception of two dogs that developed small
subendocardial infarction, there was no identifiable risk area
Figure 4. Mean MCE perfusion defect size in all dogs, expressed as a
percent of the short axis left ventricular slice. MCE 5 myocardial contrast
echocardiography.
Figure 5. Ratio of videointensity in the LAD relative to LCX bed as a
function of time. LAD 5 left anterior descending coronary artery; LCX 5
left circumflex coronary artery.
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on the MCE images six weeks later, despite the presence of
total LAD occlusion. The radiolabeled microsphere data
confirm that blood flow to the occluded LAD bed was
comparable with LCX flow by six weeks and significantly
greater than flow to the acutely occluded LAD bed mea-
sured on day 0, indicating the interval development of
functionally significant collaterals.
Serial MCE imaging highlighted two features of the
natural history of collateral development in this model.
First, it was shown that the restoration of flow to the risk
bed begins relatively early after ameroid placement. This
pattern is consistent with previous postmortem canine
studies, indicating that the maturation of pre-existing col-
laterals, as opposed to de novo growth of vessels, constitutes
an early phase of collateral development in chronically
ischemic dogs (10,25).
Second, the MCE images indicate that the spatial pattern
of collateral development appears to commence at the lateral
borders of the risk bed, as shown by the progressive inward
migration of risk bed borders over the course of six weeks,
culminating in normalization of flow to the LAD bed. This
observation is consistent with previous speculations con-
cerning the existence of a collateral-dependent lateral risk
bed border (26,27). In an acute model of coronary occlusion,
Kaul et al. (28) found that the lateral borders of a risk bed
were dynamic and could acutely change as a function of
collateral perfusion pressure in the contralateral artery. The
findings of this study support the existence of a lateral
border and suggest that, in the dog, collateral flow initially
emanates from this region.
Advantages of MCE for imaging collateral development.
Currently available techniques to study the coronary collat-
eral circulation in vivo are limited. Coronary angiography is
capable of delineating epicardial coronary anatomy but
cannot define vessels less than 100 microns in size and is,
thus, suboptimally suited for demonstrating total perfusion
through collaterals (9). Furthermore, serial arteriographic
assessment of collateral growth, in response to an interven-
tion for example, is neither practical nor feasible. Similarly,
radionuclide techniques such as thallium-201 scintigraphy
or positron emission tomography are limited in spatial
resolution and cannot be performed repetitively in short
periods of time.
Anatomic and morphometric methods, such as postmor-
tem casts, dyes and colored microspheres, have been used to
identify coronary collateral macrovascular and microvascular
anatomy (29–32). Using colored microspheres in canines,
Cicutti et al., described the presence of an interface transi-
tion zone, which included a boundary watershed zone
between two perfusion beds (29). This method, however,
requires ex vivo analysis of myocardial tissue, precludes serial
study of collateral development and, as with other anatomic
methods, does not provide information on tissue perfusion.
Pearlman and colleagues (33) used magnetic resonance
imaging with gadodiamide to assess myocardial perfusion in
a porcine model of vascular endothelial growth factor-
mediated angiogenesis. This approach, however, is limited
by the heterogeneity in the intravascular flow of gadodia-
mide (which may alter the signal intensity) and the fact that
gadodiamide extravasates from the intravascular space and
is, thus, not a pure intravascular tracer.
Myocardial contrast echocardiography has unique advan-
tages for the assessment of collateral blood flow. The
microbubbles are physiologically inert, nonocclusive and
remain entirely within the intravascular space (13). As
shown in Figures 3 and 4, echocardiography delineates
changes in the location of perfusion bed borders resulting
from angiogenesis with a spatial resolution unavailable using
other clinical imaging techniques.
The ability to spatially locate regions of collateral devel-
opment can be a useful tool for understanding the physiol-
ogy of angiogenesis. Unlike the anatomic methods de-
scribed above, MCE interrogates the microvascular
compartment and, thus, conveys information at the level of
nutritive perfusion (34). Myocardial contrast echocardiog-
raphy has the potential to provide more than mere anatomic
information, such as physiologic data on collateral flow
reserve (35). Furthermore, MCE can be performed repeti-
tively.
Using intracoronary injections of microbubbles, Sabia et
al. (2) demonstrated the existence of extensive collateral
circulation in patients with recent infarction and a totally
occluded infarct-related coronary artery. In that study, there
was a poor correlation between the presence of angiographic
and MCE collaterals, and it was the MCE collaterals that
predicted improvement in left ventricular systolic function
after revascularization.
The evaluation of collaterals using MCE has previously
been limited by the requirement for intracoronary injection
due to the fragility of air-filled microbubbles. The develop-
ment of more robust microbubbles, and the observation that
these microbubbles exhibit nonlinear acoustic behavior at
ultrasound frequencies used in medical imaging, have been
the bases for harmonic imaging (36). This study extends the
work of Sabia et al. by demonstrating that not only can the
existence of collaterals be identified at a given moment using
MCE but also that the development of these collaterals can
be tracked serially without the requirement for invasive
coronary manipulation.
The relative contribution of microvascular versus macro-
vascular (epicardial) collateral development in this canine
model has been debated (37,38). Although there are data to
suggest the predominance of epicardial collateral maturation
in the canine model (25), some studies also suggest a
substantial contribution of new microvessel growth to the
restoration of perfusion to the occluded bed (39). This study
does not answer this question, but MCE may have the
potential to parcel out these distinctions. Because 95% of
intramyocardial blood volume consists of capillaries, the
MCE image is predominantly a representation of capillary
volume (40). We have previously shown, using intracoro-
nary microbubble injection, that MCE can detect changes
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in coronary blood volume in the presence of nonflow
limiting coronary stenosis (41). Using continuous intrave-
nous contrast infusion and triggered harmonic imaging at
varying cycles in acute models, Wei and colleagues (34) have
recently suggested that MCE is capable of quantifying
capillary cross sectional area. Using similar imaging meth-
ods, Linka et al. (42) have described a method for quanti-
fying endocardial/epicardial intramyocardial volume ratios
using MCE. With these unique capabilities for interrogat-
ing intramyocardial blood volume and its transmural distri-
bution, MCE may yield insight into the pathophysiologic
questions concerning micro- versus macrovascular collateral
development during chronic myocardial ischemia.
Study limitations. This is the first MCE demonstration of
the natural history of collateral development. The approach
using harmonic imaging and intravenous contrast agents for
MCE is relatively new, and the optimal strategies for
imaging have not been fully defined. For example, intrave-
nous injection results in intense left ventricular cavity
opacification, leading to attenuation and obscuration of
perfusion bed borders. Additionally, although changes in
relative videointensity measurements directionally paralleled
changes in flow, this study did not establish a precise
quantitative relationship between flow and videointensity
measurements.
Approaches to quantification of blood flow using intra-
venous contrast injection are confounded by the extended
nature of the contrast bolus, which precludes the application
of indicator dilution theory, and the protracted exposure of
bubbles to ultrasound, which results in microbubble de-
struction (40). Wei et al. (34) have recently reported a novel
method based on the occurrence of microbubble destruction
that uses continuous infusion of microbubbles with trig-
gered imaging at varying intervals, which may have the
potential to quantify both perfusion and intramyocardial
blood volume (34) while minimizing the pitfalls of acoustic
attenuation.
This study used an experimental model in which large
resting perfusion defects were initially present and the
subsequent collateral response was robust, thus favoring
MCE detection of obvious changes in perfusion with time.
In the application to human patients in whom angiogenesis
is the therapeutic end point in question, resting defects may
not be present, and the magnitude of change in perfusion
resulting from collateral development may be less. It re-
mains to be seen whether MCE can detect these subtler
differences. In instances where there are no perfusion defects
because resting flow remains normal despite severe coronary
artery disease, MCE during pharmacologic stress may be
required to elicit abnormalities in collateral flow reserve and
to evaluate for changes in flow reserve resulting from
angiogenic therapies. Moreover, the quantitative methods
reported by Wei et al. (34) may enable more precise
detection of subtle changes in perfusion resulting from
collateral growth.
Future clinical applications. There is individual variability
in the propensity to develop collaterals, with the result being
that some patients with coronary artery disease have more
collaterals than others and are, thus, more protected against
ischemia. Novel approaches to stimulating the growth of
new vessels, such as therapeutic angiogenesis, have shown
promise in both animal and early clinical trials (5–8).
Myocardial contrast echocardiography may prove valuable
in the progress of this effort in several ways. First, it provides
a tool that may allow basic investigation of the physiology of
collateral development in vivo that was heretofore not
possible; its potential to quantify microvascular coronary
volume (32) and distinguish endocardial-epicardial flow
ratios (42) could broaden our understanding of the process
of angiogenesis. Second, MCE could have practical clinical
applications in the area of therapeutic angiogenesis: one of
the challenges in designing clinical trials in myocardial
angiogenesis is to delineate the optimal end points for
defining therapeutic efficacy, some of which must necessar-
ily include indexes of perfusion. The ability to monitor
tissue perfusion serially in response to angiogenic treatments
will be important to the advancement of this revasculariza-
tion strategy to clinical settings. As shown in this study,
MCE provides a readily accessible, portable, high resolu-
tion, nonradiographic method for evaluating collateral de-
velopment over time, and may be a powerful tool for
noninvasively mapping the efficacy of therapeutic angio-
genic strategies.
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